Benzinga | Apr 29, 2021 07:13AM EDT

Abiomed Q4 EPS $1.24 Beats $1.10 Estimate, Sales $241.25M Beat $230.38M Estimate

Abiomed (NASDAQ:ABMD) reported quarterly earnings of $1.24 per share which beat the analyst consensus estimate of $1.10 by 12.73 percent. This is a 24 percent increase over earnings of $1.00 per share from the same period last year. The company reported quarterly sales of $241.25 million which beat the analyst consensus estimate of $230.38 million by 4.72 percent. This is a 16.74 percent increase over sales of $206.66 million the same period last year.